Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-113117
Filing Date
2010-12-13
Accepted
2010-12-13 14:57:43
Documents
15
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F w80785e20vf.htm 20-F 1139466
2 EX-4.2 w80785exv4w2.htm EX-4.2 406274
3 EX-4.3 w80785exv4w3.htm EX-4.3 97029
4 EX-4.4 w80785exv4w4.htm EX-4.4 94987
5 EX-4.5 w80785exv4w5.htm EX-4.5 94152
6 EX-4.6 w80785exv4w6.htm EX-4.6 96670
7 EX-4.7 w80785exv4w7.htm EX-4.7 106051
8 EX-4.8 w80785exv4w8.htm EX-4.8 105297
9 EX-4.9 w80785exv4w9.htm EX-4.9 104987
10 EX-8.1 w80785exv8w1.htm EX-8.1 5448
11 EX-12.1 w80785exv12w1.htm EX-12.1 7906
12 EX-12.2 w80785exv12w2.htm EX-12.2 7828
13 EX-13.1 w80785exv13w1.htm EX-13.1 4426
14 GRAPHIC w80785w8078501.gif GRAPHIC 98561
15 GRAPHIC w80785w8078502.gif GRAPHIC 88547
  Complete submission text file 0000950123-10-113117.txt   2529984
Mailing Address 107 NORTH RYDE SYDNEY C3 1670
Business Address 140 WICKS RD NORTH RYDE NEW SOUTH WALES 2113 C3 2113 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 101247657
SIC: 2834 Pharmaceutical Preparations